Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04508140
Title Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Highlight Therapeutics
Indications

colorectal cancer

gastroesophageal junction adenocarcinoma

stomach cancer

Therapies

BO-112 + Pembrolizumab

Age Groups: adult | senior
Covered Countries ITA | ESP | BEL


No variant requirements are available.